How to Screen for Diabetic Polyneuropathy: What You Need to Know
How to Screen for Diabetic Polyneuropathy: What You Need to Know
The Big Picture
Screening for diabetic polyneuropathy is crucial for early intervention and prevention of complications.
Contents
- Who Needs Screening?
- Essential Screening Steps
- Simple Screening Tools
Who Needs Screening?
All patients with type 2 diabetes should be screened at diagnosis, while type 1 diabetes patients need screening five years after diagnosis. Those with prediabetes and symptoms should also be screened. Annual screening is recommended for those without symptoms to catch any developments early.
Essential Screening Steps
Screening involves a detailed history and physical examination to assess nerve function. Tests include checking sensitivity to light touch and vibration, and evaluating reflexes. These steps help identify early signs of neuropathy before severe symptoms develop.
Simple Screening Tools
Several tools, like the Michigan Neuropathy Screening Instrument, offer quick assessments. These tools evaluate symptoms and physical signs, assisting healthcare professionals in diagnosing diabetic polyneuropathy efficiently. Early detection can lead to better management and reduced complications.
FAQs
When should type 1 diabetes patients be screened?
Five years after diagnosis.
What are key screening tests for neuropathy?
Tests for light touch, vibration sensitivity, and reflexes are key.
Why is annual screening important?
It helps catch neuropathy developments early.
What is the Michigan Neuropathy Screening Instrument?
A tool for assessing symptoms and signs of neuropathy.
Next Steps
Regular screening can significantly impact the management of diabetic polyneuropathy.
Additional References
- Herman WH, Pop-Busui R, Braffett BH, et al. Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications. Diabet Med 2012; 29:937.
- Pop-Busui R, Boulton AJ, Feldman EL, et al. Diabetic Neuropathy: A Position Statement by the American Diabetes Association. Diabetes Care 2017; 40:136.
This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic.